Cloud DX begins trading on TSX Venture Exchange

TORONTO – Cloud DX Inc. announced the commencement of trading on Thursday April 15th, 2021, on the TSX Venture Exchange under the ticker symbol CDX. The company’s listing is the result of the successful Qualifying Transaction (as defined in the CPC Policy) with Roosevelt Capital Group Inc., which included an oversubscribed brokered private placement of approximately $6.1 million.

“The board, management and in fact the whole team at Cloud DX is pleased that we have achieved this important milestone,” said Robert Kaul (pictured), co-founder & CEO of the company. “This is another important step in the six-and-a-half-year mission at Cloud DX to make healthcare better for everyone, by improving the availability, efficacy and ease of use of virtual care and remote patient monitoring.”

About Cloud DX
Cloud DX is a leader in virtual healthcare and digital medicine with rapidly growing sales across North America. Our complete remote patient monitoring platform incorporates proprietary medical devices, mobile apps, clinical dashboards, artificial intelligence and EMR integration. Cloud DX now provides products and services to hospitals, healthcare providers and provincial health departments across North America. In 2020, Cloud DX was a co-recipient of the Roche COVID Challenge award and is widely recognized for their ground-breaking med-tech innovations, including winning the Qualcomm Tricorder XPRIZE Bold Epic Innovator Award, Fast Company magazine “World Changing Idea” and most recently a 2021 Edison Award.